Additionally, targeting PPARGC1A, a key regulator of mitochondrial biogenesis and energy metabolism, with PPAR agonists such as fenofibrate could mitigate PFAS-induced metabolic reprogramming in liver cancer cells. Here, PPARGC1A is linked to liver cancer.